KBC Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $207K | Sell |
1,366
-74,940
| -98% | -$11.4M | ﹤0.01% | 850 |
|
|
2025
Q1 | $11.5M | Sell |
76,306
-9,056
| -11% | -$1.36M | 0.04% | 334 |
|
|
2024
Q4 | $15.8M | Buy |
85,362
+796
| +0.9% | +$147K | 0.04% | 309 |
|
|
2024
Q3 | $16.7M | Sell |
84,566
-50,319
| -37% | -$9.91M | 0.05% | 292 |
|
|
2024
Q2 | $27.9M | Sell |
134,885
-741
| -0.5% | -$153K | 0.08% | 200 |
|
|
2024
Q1 | $36.7M | Sell |
135,626
-80,013
| -37% | -$21.7M | 0.12% | 171 |
|
|
2023
Q4 | $51M | Sell |
215,639
-2,875
| -1% | -$680K | 0.18% | 124 |
|
|
2023
Q3 | $42.8M | Buy |
218,514
+213,341
| +4,124% | +$41.8M | 0.17% | 127 |
|
|
2023
Q2 | $1.09M | Buy |
5,173
+80
| +2% | +$16.8K | ﹤0.01% | 690 |
|
|
2023
Q1 | $1.03M | Sell |
5,093
-1,738
| -25% | -$351K | ﹤0.01% | 716 |
|
|
2022
Q4 | $1.49M | Buy |
6,831
+3,653
| +115% | +$796K | 0.01% | 648 |
|
|
2022
Q3 | $625K | Sell |
3,178
-19
| -0.6% | -$3.74K | ﹤0.01% | 728 |
|
|
2022
Q2 | $684K | Buy |
3,197
+225
| +8% | +$48.1K | ﹤0.01% | 716 |
|
|
2022
Q1 | $844K | Sell |
2,972
-65,014
| -96% | -$18.5M | ﹤0.01% | 723 |
|
|
2021
Q4 | $25.6M | Sell |
67,986
-2,650
| -4% | -$998K | 0.08% | 232 |
|
|
2021
Q3 | $29.1M | Buy |
70,636
+54,410
| +335% | +$22.5M | 0.11% | 207 |
|
|
2021
Q2 | $6M | Buy |
+16,226
| New | +$6M | 0.01% | 584 |
|
|
2015
Q3 | – | Sell |
-2,047
| Closed | -$144K | – | 1347 |
|
|
2015
Q2 | $144K | Sell |
2,047
-248
| -11% | -$17.4K | ﹤0.01% | 1182 |
|
|
2015
Q1 | $182K | Sell |
2,295
-877
| -28% | -$69.5K | ﹤0.01% | 1143 |
|
|
2014
Q4 | $202K | Sell |
3,172
-62,561
| -95% | -$3.98M | ﹤0.01% | 1190 |
|
|
2014
Q3 | $3.93M | Sell |
65,733
-5,764
| -8% | -$344K | 0.14% | 209 |
|
|
2014
Q2 | $3.83M | Buy |
+71,497
| New | +$3.83M | 0.04% | 444 |
|